jazz
-
Spine
IMPLANET Signs a Distribution Agreement With Sanyou Medical in China and a Technological Partnership for the Development of a New Product Range
Finalization of the distribution agreement in China for Implanet’s JAZZ® platformTechnological know-how synergies for the development of a brand-new European hybrid…
Read More » -
Spine
Implanet Announces a Commercial, Technological and Financial Partnership With Sanyou Medical, a Chinese Manufacturer of Medical Devices for Spine Surgery
Commercial partnership: Agreement to distribute Implanet’s JAZZ® platform in China, the world’s largest market (by volume) for spine surgeryTechnological partnership: Joint…
Read More » -
Spine
IMPLANET Announces the First Surgical Procedures in the United States with JAZZ™ PF
JAZZ™ PF: a simple, innovative and proprietary addition to the JAZZ® rangeAddressable annual market of almost $350 million in the United…
Read More » -
Financial
Implanet Reports Q1 2021 Revenue of €1.7 Million, Driven by the Dramatic Growth of Its Spine Activity
April 20, 2021 Global revenue growth: +7%, driven by +13% increase in direct salesGrowth in JAZZ® Spine activity: +41% A webinar…
Read More » -
Spine
Implanet Signs Distribution Agreement for Its JAZZ® Platform Products in Mexico
November 4, 2020 BORDEAUX, France & BOSTON–(BUSINESS WIRE)–Regulatory News: IMPLANET (Paris:ALIMP) (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings…
Read More » -
Recon
CE Marking Renewed into 2024 for IMPLANET MADISON Knee Prosthesis and JAZZ® Spine Ranges
June 9, 2020 BORDEAUX, France & BOSTON–(BUSINESS WIRE)–Regulatory News: IMPLANET (Euronext Growth : ALIMP, FR0013470168, eligible for PEA-PME equity savings…
Read More » -
Spine
Strategic Partnership between SeaSpine and Implanet in the United States
February 21, 2019 BORDEAUX, France & BOSTON–(BUSINESS WIRE)–Regulatory News: Implanet (Paris:ALIMP) (OTCQX:IMPZY) (Euronext Growth: ALIMP, FR0010458729, eligible for PEA-PME equity savings plans), a…
Read More » -
Spine
Implanet Opens Another Direct Market in Europe with the First Surgery Jazz® in Belgium
October 16, 2018 BORDEAUX, France & BOSTON–(BUSINESS WIRE)–Regulatory News: IMPLANET (Paris:ALIMP) (OTCQX:IMPZY) (Euronext Growth: ALIMP, FR0010458729, eligible for PEA-PME equity…
Read More » -
Spine
Implanet UK announces its first surgery in the United Kingdom
October 04, 2018 BORDEAUX, France & BOSTON–(BUSINESS WIRE)–Regulatory News: Implanet (Paris:ALIMP) (OTCQX:IMPZY) (Euronext Growth: ALIMP, FR0010458729, eligible for PEA-PME equity savings plans;…
Read More » -
Spine
Implanet Strengthens Its Presence in Australia and New Zealand by Signing an Exclusive Distribution Partnership
March 14, 2017 BORDEAUX, France & BOSTON–(BUSINESS WIRE)–Regulatory News: IMPLANET (Paris:IMPL) (OTCQX:IMPZY) (Euronext: IMPL, FR0010458729, PEA-PME eligible; OTCQX: IMPZY), a…
Read More » -
Hospitals
Implanet Announces Global Marketing Clearance of the New JAZZ FRAME®
January 25, 2017 BORDEAUX, France & BOSTON–(BUSINESS WIRE)–Regulatory News: IMPLANET (Paris:IMPL) (OTCQX:IMPZY) (Euronext: IMPL, FR0010458729, PEA-PME eligible; OTCQX: IMPZY), a…
Read More » -
Hospitals
Implanet Announces New Patent Further Strengthening JAZZ Platform Intellectual Property
January 05, 2017 BORDEAUX, France & BOSTON–(BUSINESS WIRE)–Regulatory News: IMPLANET (Euronext: IMPL, FR0010458729, PEA-PME eligible) (Paris:IMPL) (OTCQX:IMPZY), a medical technology…
Read More » -
Spine
Implanet Presents JAZZ Band Clinical Results in Hypokyphotic Idiopathic Scoliosis Patients
December 06, 2016 BORDEAUX, France & BOSTON–(BUSINESS WIRE)–Regulatory News: IMPLANET (Paris:IMPL) (OTCQX:IMPZY) (Euronext: IMPL, FR0010458729, PEA-PME eligible; OTCQX: IMPZY), a medical…
Read More » -
Spine
IMPLANET: Successful First Surgical Procedures with the New Jazz Lock® Implant
September 14, 2016 BORDEAUX, France & BOSTON–(BUSINESS WIRE)–Regulatory News: IMPLANET (Paris:IMPL) (OTCQX:IMPZY) (Euronext: IMPL, FR0010458729, PEA-PME eligible), a medical technology…
Read More » -
Hospitals
Implanet strengthens intellectual property protection of JAZZ through 2032 by obtaining a key United States patent
Bordeaux, Boston, August 30, 2016 – IMPLANET (Euronext: IMPL, FR0010458729, PEA-PME eligible; OTCQX: IMPZY), a medical technology company specializing in…
Read More »